IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mink Therapeutics Inc (INKT)

CUSIP: 603693201 | NYSE | Healthcare · Biotechnology | Micro Cap | 38 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Geode Capital Management, LLC18,759
0.0% of portfolio›$235.5K
US Bancorp \de\1,995
0.0% of portfolio›$25.0K
UBS Group AG1,462
0.0% of portfolio›$18.3K
Paladin Partners, LLC500
0.0% of portfolio›$6.3K
Covestor Ltd119
0.0% of portfolio›$1
Caitong International Asset Management Co., Ltd18
0.0% of portfolio›$226
Game Plan Financial Advisors, LLC16
0.0% of portfolio›$201
Clearstead Advisors, LLC14
0.0% of portfolio›$176
Key FInancial Inc4
0.0% of portfolio›$50
StyleTurnoverLocationFiled
Geode Capital Management, LLC
18,759$235.5K0.0%IndexVery LowBoston, MA2026-11-06
US Bancorp \de\
1,995$25.0K0.0%CoreLowMinneapolis, MN2026-11-05
UBS Group AG
1,462$18.3K0.0%CoreMediumZurich, Switzerland2026-11-10
Paladin Partners, LLC
500$6.3K0.0%ETFVery LowHartland, WI2026-10-06
Covestor Ltd
119$10.0%ValueHighLondon, United Kingdom2026-10-30
Caitong International Asset Management Co., Ltd
18$2260.0%GrowthVery HighHong Kong, South Korea2026-10-29
Game Plan Financial Advisors, LLC
16$2010.0%CoreMediumWestlake, OH2026-11-10
Clearstead Advisors, LLC
14$1760.0%ETFLowCleveland, OH2026-11-06
Key FInancial Inc
4$500.0%ETFLowWest Chester, PA2026-11-02